Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia

Updates in Philadelphia-positive acute lymphoblastic leukemia treatment are highlighted following ASCO 2023.

EP. 1: Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL

June 28th 2023

Amanda Przespolewski, DO, and Ibrahim Aldoss, MD define and discuss how to diagnose patients with Ph+ALL.

EP. 2: Evolving Standard of Care for Patients Diagnosed with Ph+ ALL

June 28th 2023

Drs Aldoss and Przespolewski evaluate the changing treatment landscape for patients diagnosed with Ph+ ALL.

EP. 3: Recent Updates from the PhALLCON Study

July 5th 2023

Medical experts highlight recent findings from the PhALLCON study.

EP. 4: Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL

July 5th 2023

Dr Aldoss discusses the role ponatinib and blinatumomab in the management of Ph+ALL.

EP. 5: Notable Advancements in Treatment for ALL

July 12th 2023

Key advances in ALL treatment from ASCO 2023 are discussed by Dr Przespolewski.

EP. 6: Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL

July 12th 2023

With their final thoughts, medical experts share unmet needs in the treatment landscape of Ph+ acute lymphoblastic leukemia.